| Dr James Allen Henry, MD | |
|
1802 Braeburn Dr, Salem, VA 24153-7357 | |
| (540) 772-3547 | |
| (540) 725-5053 |
| Full Name | Dr James Allen Henry |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 35 Years |
| Location | 1802 Braeburn Dr, Salem, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619954351 | NPI | - | NPPES |
| 1619954351 | Medicaid | VA | |
| 7003411 | Medicaid | WA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastroenterology Associates Of Northern Virginia, Llc | 1759371008 | 82 |
News Archive
In a groundbreaking development, scientists at the Australian National University in Canberra have found the key to the mutation of the flu virus. This may allow the manufacturing of a life-long vaccine stopping the need for repeated vaccinations. The scientists reveal that they have found a protein in the virus that changes or mutates in order to develop resistance in the virus.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.
› Verified 2 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20080806000696 |
News Archive
In a groundbreaking development, scientists at the Australian National University in Canberra have found the key to the mutation of the flu virus. This may allow the manufacturing of a life-long vaccine stopping the need for repeated vaccinations. The scientists reveal that they have found a protein in the virus that changes or mutates in order to develop resistance in the virus.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.
› Verified 2 days ago
| Entity Name | Inova Health Care Services - Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427369578 PECOS PAC ID: 8426241647 Enrollment ID: O20140224000430 |
News Archive
In a groundbreaking development, scientists at the Australian National University in Canberra have found the key to the mutation of the flu virus. This may allow the manufacturing of a life-long vaccine stopping the need for repeated vaccinations. The scientists reveal that they have found a protein in the virus that changes or mutates in order to develop resistance in the virus.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.
› Verified 2 days ago
| Entity Name | Advanced Digestive Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629462171 PECOS PAC ID: 3375857725 Enrollment ID: O20150730010749 |
News Archive
In a groundbreaking development, scientists at the Australian National University in Canberra have found the key to the mutation of the flu virus. This may allow the manufacturing of a life-long vaccine stopping the need for repeated vaccinations. The scientists reveal that they have found a protein in the virus that changes or mutates in order to develop resistance in the virus.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.
› Verified 2 days ago
| Entity Name | Gastroenterology Associates Of Northern Virginia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205884368 PECOS PAC ID: 1759371008 Enrollment ID: O20170329002823 |
News Archive
In a groundbreaking development, scientists at the Australian National University in Canberra have found the key to the mutation of the flu virus. This may allow the manufacturing of a life-long vaccine stopping the need for repeated vaccinations. The scientists reveal that they have found a protein in the virus that changes or mutates in order to develop resistance in the virus.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Allen Henry, MD 1802 Braeburn Dr, Salem, VA 24153-7357 Ph: (540) 772-3547 | Dr James Allen Henry, MD 1802 Braeburn Dr, Salem, VA 24153-7357 Ph: (540) 772-3547 |
News Archive
In a groundbreaking development, scientists at the Australian National University in Canberra have found the key to the mutation of the flu virus. This may allow the manufacturing of a life-long vaccine stopping the need for repeated vaccinations. The scientists reveal that they have found a protein in the virus that changes or mutates in order to develop resistance in the virus.
The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted to announce that the Malcolm Campbell Memorial Prize for 2015 has been awarded to Miles Congreve (Vice President of Chemistry), Fiona Marshall (Chief Scientific Officer and co-founder) and Malcolm Weir (Chief Executive Officer and co-founder) for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics since the company was founded in 2007.
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor's prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.
› Verified 2 days ago
Amando Valencia Esguerra, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1970 Boulevard, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-224-1923 | |
Dr. Rudolf Ulirsch, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-224-1923 | |
Wenxue Xing, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1802 Braeburn Dr, Salem, VA 24153 Phone: 540-772-5928 Fax: 540-725-5053 | |
Dr. Lampros Steve Karageorge, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Laboratory 113, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-224-1923 | |
Basma Elhaddad, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-777-1430 Fax: 540-777-1449 | |
Joy Bradley, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1802 Braeburn Dr, Salem, VA 24153 Phone: 540-772-5928 |